An updated systematic review and meta-analysis on the efficacy and tolerability of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes with moderate to severe chronic kidney disease

OBJECTIVE: This updated meta-analysis determines the effect of dipeptidyl peptidase-4 inhibitors on glycemic and tolerability outcomes in patients with type 2 diabetes mellitus and chronic kidney disease with glomerular filtration rate of ⩽60 mL/min or on dialysis. METHODS: In all, 14 citations were...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh-Franco, Devada, Harrington, Catherine, Tellez-Corrales, Eglis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968114/
https://www.ncbi.nlm.nih.gov/pubmed/27516879
http://dx.doi.org/10.1177/2050312116659090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968114/
https://www.ncbi.nlm.nih.gov/pubmed/27516879
http://dx.doi.org/10.1177/2050312116659090

Ejemplares similares